Correction
Zyflamend Sensitizes Tumor Cells to TRAIL-Induced Apoptosis Through Up-Regulation of Death Receptors and Down-Regulation of Survival Proteins: Role of ROS-Dependent CCAAT/Enhancer-Binding Protein-Homologous Protein Pathway
Paper Information
Record ID:
17954
Author(s):
Journal:
Publication Date:
March 01, 2012
Retraction Date:
January 10, 2013
(12.9 years years ago)
Subjects:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Mary Ann Liebert
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Correction Details
Citations (20)
20
Total Citations18
Post-Retraction(90.0%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
12
After 2+ years
3535
Days since retraction (latest)
Paper citing Resveratrol Enhances Antitumor Activity of TRAIL i...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Zyflamend Sensitizes Tumor Cells to TRAIL-Induced ...
Unknown Authors
Unknown Journal
Published: Sep 2022
3535 days after retraction
Volatile oil of Teucrium alopecurus sensitizes colon cancer cells to TRAIL-induced cell death
Fatma Guesmi, Sahdeo Prasad, Wiem Tahri et al. (8 authors)
Frontiers in Bioscience-Scholar
Open Access
Published: May 2021
3 citations
3 citations
3043 days after retraction
Revisiting the role of TRAIL/TRAIL-R in cancer biology and therapy
Deepika Singh, Mallika Tewari, Sunita Singh et al. (4 authors)
Future Oncology
Published: Jan 2021
33 citations
33 citations
2918 days after retraction
Paper citing Zyflamend Sensitizes Tumor Cells to TRAIL-Induced ...
Unknown Authors
Unknown Journal
Published: Jan 2021
2913 days after retraction
Zyflamend induces apoptosis in pancreatic cancer cells via modulation of the JNK pathway
Dexter Puckett, Mohammed Alquraishi, Dina Alani et al. (8 authors)
Cell Communication and Signaling
Open Access
Published: Aug 2020
6 citations
6 citations
2773 days after retraction
Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway
Yanshi Xue, Lin Yang, Junzun Li et al. (11 authors)
OncoTargets and Therapy
Open Access
Published: Jul 2018
5 citations
5 citations
1998 days after retraction
Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties
Amber MacDonald, Ahmed Bettaieb, Dallas R. Donohoe et al. (7 authors)
BMC Complementary and Alternative Medicine
Open Access
Published: Jun 2018
12 citations
12 citations
1985 days after retraction
Paper citing MiR-494 is regulated by ERK1/2 and modulates TRAIL...
Unknown Authors
Unknown Journal
Published: Mar 2018
1889 days after retraction
Metabolomics Approach in the Study of the Well-Defined Polyherbal Preparation Zyflamend
Eric D. Tague, Allen K. Bourdon, Amber MacDonald et al. (10 authors)
Journal of Medicinal Food
Published: Dec 2017
7 citations
7 citations
1796 days after retraction
Paper citing Resveratrol Enhances Antitumor Activity of TRAIL i...
Unknown Authors
Unknown Journal
Published: Dec 2016
1434 days after retraction
Chapter 11 Zyfl amend and Prostate Cancer Therapy
Jay Whelan, Yi Zhao, E‐Chu Huang et al. (5 authors)
Traditional herbal medicines for modern times
Published: Dec 2016
1421 days after retraction
Zyflamend, a polyherbal mixture, inhibits lipogenesis and mTORC1 signalling via activation of AMPK
Yi Zhao, Dallas R. Donohoe, E‐Chu Huang et al. (4 authors)
Journal of Functional Foods
Open Access
Published: Jul 2015
9 citations
9 citations
925 days after retraction
Paper citing gamma-Tocotrienol Promotes TRAIL-Induced Apoptosis...
Unknown Authors
Unknown Journal
Published: Aug 2014
582 days after retraction
Targeting death receptors for TRAIL by agents designed by Mother Nature
Sahdeo Prasad, Ji Hye Kim, Subash C. Gupta et al. (4 authors)
Trends in Pharmacological Sciences
Published: Aug 2014
59 citations
59 citations
581 days after retraction
Paper citing ROS and CHOP Are Critical for Dibenzylideneacetone...
Unknown Authors
Unknown Journal
Published: Apr 2014
446 days after retraction
Zyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cells
E‐Chu Huang, Yi Zhao, Guoxun Chen et al. (8 authors)
BMC Complementary and Alternative Medicine
Open Access
Published: Feb 2014
19 citations
19 citations
407 days after retraction
Paper citing Zyflamend Sensitizes Tumor Cells to TRAIL-Induced ...
Unknown Authors
Unknown Journal
Published: Feb 2014
387 days after retraction
Paper citing Zerumbone Enhances TRAIL-Induced Apoptosis through...
Unknown Authors
Unknown Journal
Published: Nov 2013
295 days after retraction
Paper citing Zyflamend Sensitizes Tumor Cells to TRAIL-Induced ...
Unknown Authors
Unknown Journal
Published: Jul 2012
163 days before retraction
Quick Stats
Total Citations:
20
Years Since Retraction:
12.9 years
Open Access:
Yes
Last Checked:
Never